Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications.

Supplies of high-demand obesity treatments are improving, but that doesn’t mean they're easier to get.

New recommendations on how to define obesity would reduce the emphasis on body mass index and also take into account health problems from extra weight and other measurements.